08.03.2011 - Genzyme Chief Executive Henri Termeer is set to walk away with nearly $160 million when the sale of his company to French drugmaker Sanofi-Aventis is final - and stands to earn...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)